Key Takeaways Tirzepatide (Zepbound) produces greater average weight loss than semaglutide (Wegovy) across both clinical trials and the first direct head-to-head comparison, 20.9% versus 14.9% in separate Phase 3 trials, and 20.2% versus 13.7% in the SURMOUNT-5 trial published in the New England Journal of Medicine
Lets take a deeper look
After reconstitution: store the solution at 28 C (refrigerated) and protect it from light
If you are currently using tirzepatide combined with L-Carnitine and want to continue with this formulation for another round, we encourage you to order before January 31st as this is the final day we will be taking order for this product
and For outsourcing facilities compounding under Section 503B of the FD&C : May 22, 2025, or until the District Court issues a decision on the OFAs preliminary injunction motion, whichever is later
Do I need B12, vitamin D, iron, or calcium based on my diet pattern